Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI study.
Imran H YusufChristin HeneinSobha SivaprasadPublished in: Eye (London, England) (2023)
Keyphrases